Rs. 9,100 Mn
Primary Product:
ECM
Secondary Product:
IPO
Date:
Mar 19
Primary Product
PE
Secondary Product
IPO
Date
March 2021
Primary Product
PE
Secondary Product
IPO
Date
March 2021
Suryoday is one of the leading SFBs with regards to net interest margins, return on assets, yields and deposit growth. It also has the lowest cost-to-income ratio among SFBs in the country. The deal witnessed strong participation from marquee anchor investors (~26% to FIIs and ~74% to DIIs, with a healthy mix of Mutual Funds and Insurance Companies).
The IPO also received good response with all categories being over-subscribed despite multiple equity offerings tapping the market simultaneously.
Positioned Suryoday SFB as:
1. One of the leading SFBs with high growth track record in both asset and liability franchise
2. Best-in-class cost efficiency with improving operating efficiency through digitization
3. Robust earnings and sustainable return profile
4. Prudent risk management, high capital adequacy and focus on data analytics
Axis Capital highlighted the strength of company while Covid impact was still evolving along with the credit cost issues in MFI segment, and completed a Pre IPO placement with a marquee public market investor, garnering momentum for the IPO.
As the left lead banker, Axis Capital advised the company on various deal contours, regulatory guidance and timelines, on appropriately timing the marketing efforts & launching the issue strategically considering evolving business and market conditions. In addition to obtaining early subscriptions for the QIB book, leveraged its HNI and Retail network to secure an overscription across investor categories.
Transactions
Rs. 7,000 Mn
Primary Product:
–
Secondary Product:
–
Date:
Oct 20
Rs. 15,000 Mn
Primary Product:
M&A
Secondary Product:
PE Buy Out
Date:
Dec 2020
Rs. 3,220 Mn
Primary Product:
–
Secondary Product:
–
Date:
Apr 21
12,000 million
Primary Product:
PE
Secondary Product:
IPO
Date:
October 2021
25,000 million
Primary Product:
PE
Secondary Product:
QIP
Date:
August 2021
37,880 million
Primary Product:
ECM
Secondary Product:
QIP
Date:
May 2021
5,810 million
Primary Product:
PE
Secondary Product:
IPO
Date:
March 2021
6,260 million
Primary Product:
PE
Secondary Product:
QIP
Date:
March 2021
45,000 million
Primary Product:
ECM
Secondary Product:
QIP
Date:
February 2021